Evidence map›Paper›PMID 38059183›Full record

ArticleWorld journal of clinical oncology2023

Computational exploration of the significance of

Shi-Lin Wang, Guang-Zheng Zhuo, Li-Ping Wang, Xiang-Hu Jiang, Guo-Hong Liu, Yun-Bao Pan, Yi-Rong Li

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shi-Lin WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Guang-Zheng ZhuoDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Li-Ping WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Xiang-Hu JiangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Guo-Hong LiuDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Yun-Bao PanDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
Yi-Rong LiDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China. liyirong2021@126.com.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COP9 signalosome subunit 6 (

aimTo investigate the functional and clinical relevance of

methodsWe used R software and online analysis databases to analyze the differential expression, prognosis, mutation and related functions of

resultsDifferential expression analysis and survival analysis demonstrated that

conclusionIn conclusion, this study systematically explored the significance of

Indexed as

BiomarkerCOPS6Immune infiltrationPrognostic analysisTumor mutational burden

Identifiers

PMID38059183
PMCPMC10696221
OpenAlexW4388884080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.